Media coverage of new migraine drugs gaining the marketing authorization and reimbursement status in two leading national medical journals in Finland – a qualitative study
Publication date: December 2026 Source: SSM - Qualitative Research in Health, Volume 10 Author(s): Outi Kurittu, Noora Lindgren, Piia Vuorela, Outi M.H. Salo-Ahen, Lasse Alajärvi, Frederick Ahen, Leena Saastamoinen
Media coverage of new migraine drugs gaining the marketing authorization and reimbursement status in two leading national medical journals in Finland – a qualitative study. // Social Sciences & Humanities Open. – URL: https://www.sciencedirect.com/science/article/pii/S2667321526002027?dgcid=rss_sd_all
Media coverage of new migraine drugs gaining the marketing authorization and reimbursement status in two leading national medical journals in Finland – a qualitative study. Social Sciences & Humanities Open. https://www.sciencedirect.com/science/article/pii/S2667321526002027?dgcid=rss_sd_all
“Media coverage of new migraine drugs gaining the marketing authorization and reimbursement status in two leading national medical journals in Finland – a qualitative study.” Social Sciences & Humanities Open.
@article{article29148,
title = {Media coverage of new migraine drugs gaining the marketing authorization and reimbursement status in two leading national medical journals in Finland – a qualitative study},
journal = {Social Sciences \& Humanities Open},
url = {https://www.sciencedirect.com/science/article/pii/S2667321526002027?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: SSM - Qualitative Research in Health, Volume 10 Author(s): Tove Lundberg, Emma Lundgren, Emma Wikforss, Maria Bygdell, Kajsa Järvholm
Publication date: December 2026 Source: SSM - Qualitative Research in Health, Volume 10 Author(s): David Healy, John Gilmore, Jenny King, Jenny McSharry, Oonagh Meade, Éidín Ní Shé, Lorna Sweeny, Conor Foley, Chris Noone